Concepedia

Renal Function Dose Adjustment

Renal Function Dose Adjustment is a methodological framework in chemotherapy dose normalization that modifies drug dosages based on quantified renal function to optimize therapeutic efficacy and minimize toxicity in patients with impaired kidney function.

120

Publications

7.3K

Citations

783

Authors

285

Institutions

Publications per year

2017–2026

24

Parents

Publications

120

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

, , +17

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

Vincent Launay‐Vacher, Stéphane Oudard, Nicolas Janus et al. · Cancer · 2007 · 455 citations

, , +17

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Raffaella Barone, Françoise Borson‐Chazot, Roelf Valkema et al. · PubMed · 2005 · 292 citations · Full text

, , +17

Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for Dosage

Robert C. Moellering · Annals of Internal Medicine · 1981 · 279 citations

, , +17

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Anna Sundlöv, Katarina Sjögreen Gleisner, Johanna Svensson et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 206 citations · Full text

, , +17

1–5 of 120

Authors

783

  1. DR
    David R. Newell

    Newcastle University, United Kingdom

    3 publications · 2K citations

    3

    h-index

  2. CH
    Chris H. Takimoto

    The University of Texas at San Antonio Health Science Center, United States

    3 publications · 275 citations

    3

    h-index

  3. SO
    Séamus O’Reilly

    Cork University Hospital, Ireland

    3 publications · 2K citations

    3

    h-index

  4. NJ
    Nicolas Janus

    Pitié-Salpêtrière Hospital, France

    2 publications · 649 citations

    2

    h-index

  5. AG
    Andrew Goetz

    The University of Texas at San Antonio Health Science Center, United States

    2 publications · 234 citations

    2

    h-index

1–5 of 783

Institutions

285

  1. The University of Texas at San Antonio Health Science Center

    San Antonio, United States

    5 h-index

    42 publications

    4.5K citations

  2. National Cancer Institute

    Bethesda, United States

    4 h-index

    14 publications

    403 citations

  3. Heidelberg University

    Heidelberg, Germany

    4 h-index

    14 publications

    800 citations

  4. Karolinska University Hospital

    Stockholm, Sweden

    3 h-index

    2 publications

    31 citations

  5. Tufts Medical Center

    Boston, United States

    3 h-index

    8 publications

    290 citations

  6. Sorbonne Université

    Paris, France

    3 h-index

    9 publications

    3K citations

  7. The University of Melbourne

    Melbourne, Australia

    3 h-index

    2 publications

    52 citations

  8. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    20 publications

    738 citations

1–8 of 285

Venues

  1. PubMed

    Repository · 11 publications · 575 citations

    10

    h-index

  2. Journal of Clinical Oncology

    8 publications · 2.5K citations

    8

    h-index

  3. Cancer Chemotherapy and Pharmacology

    7 publications · 233 citations

    7

    h-index

  4. European Journal of Clinical Pharmacology

    4 publications · 90 citations

    4

    h-index

  5. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 158 citations

    4

    h-index

1–5